Relmada Therapeutics

RLMD

3.2700.61% ( -0.020 )

Closed: Oct 23, 16:00:00 (EDT)

Forecast & Rating4 analysts currently cover Relmada Therapeutics, of which 4 give a positive rating. The average price target is $10.75, about 228.7% upside from the current price of $3.27. Coverage is limited, so the data is for reference only. Data as of Sep 15, 2026; this does not constitute investment advice.

Sep 15, 2026

Price forecast

$10.75228.75%

Forecast & RatingStrong buy

4analysts

Forecast dateOct 19, 2026

Forecast met24.8%

Stock price$3.27

Avg. target$6.7

High target$10

Low target$1

Strong buy

Buy

Hold

Sell

Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.